North American Nuclear Medicine Market 2022 Key Factors Major Drivers and Procurement Intelligence

Cardinal Health was the leading player in the nuclear medicine market. The company has a robust network of nuclear pharmacies and focuses on expanding its PET manufacturing capabilities.

The report "North American Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET- F-18), Therapeutic (Beta Emitters – I-131, Alpha Emitters, Brachytherapy – Y-90)), Application (Oncology, Cardiology) - Forecasts to 2024", North American nuclear medicine market is expected to reach USD 2.7 billion by 2024 from an estimated USD 2.2 billion in 2019, at a CAGR of 4.1%.

The key factors driving the growth of this market are increasing incidence and prevalence of cancer cardiac ailments and the initiatives to lessen the demand-supply gap of Mo-99.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1108

By type, the SPECT radiopharmaceutical segment is expected to account for the largest share of the diagnostic nuclear medicine market

Based on type, the North American nuclear medicine market is categorized into diagnostic and therapeutic nuclear medicine. The diagnostic nuclear medicine segment is further categorized into SPECT and PET radiopharmaceuticals. The SPECT radiopharmaceuticals segment is expected to account for the largest share of the market

By application, the PET oncology application segment is expected to account for the largest share of the market

Based on application, the North American nuclear medicine market is segmented into SPECT, PET, and therapeutic applications. The PET applications segment is further segmented into oncology, cardiology, and neurology, among others. The oncology PET application segment is projected to register the highest growth rate in the forecast period.

By procedural volume assessment, the Tc-99m procedures segment is expected to account for the largest share of the SPECT procedures market

Based on procedural volume assessment, the North American nuclear medicine market is segmented into SPECT, PET, and therapeutic procedures. The Tc-99m procedural volume segment is expected to account for the largest share of the SPECT procedural volume assessment

The US to dominate the market

The North American nuclear medicine market is segmented into the US and Canada, based on country. The US is expected to account for the largest share and also register the highest CAGR during the forecast period. The growth of this market can be attributed to the development of novel technologies for radioisotope production, government funding, and company initiatives in the country

Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=1108

Key Market Players

The prominent players in the global North American nuclear medicine market include Cardinal Health (US), GE Healthcare (US), Curium (France), Lantheus Medical Imaging (US), Bayer AG (Germany), Bracco Imaging (Italy), Eczacýbaþý-Monrol Nuclear Products (Turkey), Nordion (Canada), Advanced Accelerator Applications (France), and NTP Radioisotopes (South Africa).

This research report categorizes the North American nuclear medicine market based on type, application, procedural volume, and country.

By Type

  • Diagnostic Nuclear Medicine
  • Therapeutic Nuclear Medicine

By Application

  • Diagnostic Applications

By Procedural Volume Assessment

  • Diagnostic Procedures
  • Therapeutic Procedures

By Country

  • North America
    • US
    • Canada

Get Bundle report @ https://www.marketsandmarkets.com/RequestBundleReport.asp?id=1108

Don’t miss out on business opportunities in North American Nuclear Medicine/Radiopharmaceuticals Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

[email protected]


johnny andrew

120 Blog posts

Comments